## Abstract In this study we used the 6βminute walk distance (6MWD) to characterize ambulation over time in Duchenne/Becker muscular dystrophy (DBMD). The 6MWD was assessed in 18 boys with DBMD and 22 healthy boys, ages 4β12 years, over mean [range] intervals of 58 [39β87] and 69 [52β113] weeks, re
Reliability of the walking energy cost test and the six-minute walk test in boys with Duchenne muscular dystrophy
β Scribed by Kempen, J.C.E.; Harlaar, J.; van der Kooi, A.J.; de Groot, I.J.M.; van den Bergen, J.C.; Niks, E.H.; Verschuuren, J.J.G.M.; Brehm, M.A.
- Book ID
- 121685747
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 232 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0960-8966
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Walking abnormalities are prominent in Duchenne muscular dystrophy (DMD). We modified the 6βminute walk test (6MWT) for use as an outcome measure in patients with DMD and evaluated its performance in 21 ambulatory boys with DMD and 34 healthy boys, ages 4 to 12 years. Boys with DMD were
## Objective: To determine the test-retest reliability of the 6-minute walk test in people with fibromyalgia. ## Methods: Twenty-six subjects (27-59 years of age) performed 3 walk tests over consecutive days before and after a 4-week treatment program. reliability was determined using a one-way r